Showing results (131-140 of 331) with videos related to

Sort By:
Pageof 34
Protein Science : a Publication of the Protein Society|April 1, 1995
Locations of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor VIII (antihemophilic factor A)B A McMullen, K Fujikawa, E W Davie, et al.
Thrombosis and Haemostasis|August 1, 1996
Immunological aspects of recombinant factor VIIa (rFVIIa) in clinical useE M Nicolaisen, L L Hansen, F Poulsen, et al.
Thrombosis Research|March 1, 1991
Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteersP C Pedersen, P B Ostergaard, U Hedner, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 11, 1998
Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis modelJ Holst, A T Kristensen, H I Kristensen, et al.
Vox Sanguinis|November 5, 1999
Use of recombinant, activated factor VII in the treatment of congenital factor VII deficienciesG Mariani, M G Testa, T Di Paolantonio, et al.
Bone Marrow Transplantation|March 29, 2002
Acquired factor VII deficiency in hematopoietic stem cell transplant recipientsA A Toor, A Slungaard, U Hedner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 16, 1999
The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0E Erhardtsen, P Nony, M Dechavanne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2001
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic proceduresH A Cooper, C P Jones, E Campion, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand diseaseK M Brinkhous, U Hedner, J B Garris, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1987
On the unreliability of one-stage factor VIII:C clotting assays after infusion of factor VIII concentratesM Blombäck, H Kjellman, J P Allain, et al.
Pageof 34